In transformed cells and cancer cells, the expression levels of many translation initiation factors, including eIF4A3, are altered, indicating that eIF4A3 may be involved in carcinogenesis and tumor progression, which is a potential therapeutic target [10]. Here, EIF4A3 is linked to cancer.